ScreenPoint has assembled a world-class team of researchers and engineers with extensive experience in breast imaging, machine learning, algorithm development, and clinical research. The team is highly motivated to develop technology that can make a difference in the early detection of breast cancer. Close collaboration with radiologists ensures that products meet clinical needs and fit in the workflow of a busy screening practice. Research is aimed at achieving superior performance of detection algorithms and on understanding the impact of our device Transpara™ in clinical practice.
Lång, K., Dustler, M., Dahlblom, V. et al. Identifying normal mammograms in a large screening population using artificial intelligence. Eur Radiol (2020). https://doi.org/10.1007/s00330-020-07165-1
R. Hupse, M. Samulski, M.B. Lobbes, R.M. Mann, R. Mus, G.J. den Heeten, D. Beijerinck, R.M. Pijnappel, C. Boetes and N. Karssemeijer. Computer-aided Detection of Masses at Mammography: Interactive Decision Support versus Prompts. Radiology 2013;266:123-129.
R. Hupse, M. Samulski, M. Lobbes, A. den Heeten, M.W. Imhof-Tas, D. Beijerinck, R. Pijnappel, C. Boetes and N. Karssemeijer. Standalone computer-aided detection compared to radiologists' performance for the detection of mammographic masses. European Radiology 2013;23:93-100.
M. Samulski, R. Hupse, C. Boetes, R. Mus, G. den Heeten and N. Karssemeijer. Using Computer Aided Detection in Mammography as a Decision Support. European Radiology 2010;20:2323-2330.
M Sasaki, M Tozaki, A Rodríguez-Ruiz, D Yotsumoto, Y Ichiki, A Terawaki, S Oosako, et al. Artificial intelligence for breast cancer detection in mammography: experience of use of the ScreenPoint Medical Transpara system in 310 Japanese women Breast Cancer. ISSN 1340-6868, DOI 10.1007/s12282-020-01061-8
From RSNA 2020
S. J. Vinnicombe, O. Parr, R. Sidebottom, D. Godden, E. Cornford, I. D. Lyburn. What Impact Could AI Based Computer Aided Detection Have on the Number and Biological Relevance of Interval Cancers in a Population Based Screening Programme?
R. M. Mann, A. Rodriguez-Ruiz, I. Sechopoulos, N. Karssemeijer, A. Wanders, W. J. Mees, C. J. van Rooden. The Potential of AI for Improving Early Detection in Breast Cancer Screening to Reduce Interval Cancer Rates
A. Rodriguez-Ruiz, N. Karssemeijer, C. Balta, S. H. Heywang-Koebrunner, C. Mieskes. Using AI to Triage Which Screening Mammograms Benefit from a Double Reading Strategy
A. Rodriguez-Ruiz, N. Karssemeijer, C. Balta, S. H. Heywang-Koebrunner, C. Mieskes. Can AI Help to Increase the Positive Predictive Value of Screen-recalled Biopsies on Calcifications?
M. Bravo, R. M. Mann, A. Rodriguez-Ruiz, I. Sechopoulos, S. Hofvind, K. Pedersen, J. Wicklein, S. Kappler. Impact of Artificial Intelligence Decision Support on Breast Cancer Screening Interpretation with Single-view Wide-angle Digital Breast Tomosynthesis
S. Romero Martín, J. Luis Raya Povedano, E. Elías Cabot, A. Gubern-Merida, A. Rodríguez-Ruiz, M. Álvarez Benito. Using autonomous AI to reduce the workload of breast cancer screening with breast tomosynthesis: a retrospective validation
From ECR 2020
K. Lang. RPS 605b - Can artificial intelligence reduce the interval cancer rate in mammography screening?
A. Lauritzen. RPS 702 - Reducing the radiologist's workload by detecting normal mammograms with an AI system
From IWBI 2020
Funded by The European Regional Development Fund Netherlands/Germany, aims to assess and optimize breast cancer detection techniques in mammograms.
Funded by The European Regional Development Fund East Netherlands, aims to develop a clinically validated CAD system for mammography that is able to make optimal use of prior mammograms.
Funded by the Eurostars countries and by the European Union, aims to enhance detection algorithms in mammography and breast tomosynthesis by using the latest deep learning techniques.